It would be interesting to determine, whether the S-phase accumulation phenotype and the AS regulatory pathways (involving ZRANB2, SYF2 and ECT2-Ex5) that we identified, may be related to the cancer stem cell phenotype of Doxo-resistant cells (50). The gene discussed is SYF2; the disease is cancer.